Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Jan 21:18:201-206.
doi: 10.2147/CCID.S492503. eCollection 2025.

Unusual Cutaneous Manifestations in a Patient with a History of Hepatitis B: A Case of Scleromyxedema and Literature Review

Affiliations
Case Reports

Unusual Cutaneous Manifestations in a Patient with a History of Hepatitis B: A Case of Scleromyxedema and Literature Review

Aili Gao et al. Clin Cosmet Investig Dermatol. .

Abstract

Scleromyxedema (SM) is a rare primary cutaneous mucinosis characterized by systemic papules and scleroderma-like manifestations, often associated with monoclonal gammopathy. We present the case of a 37-year-old male with SM who developed yellowish plaques on the neck and back over three years. Histopathological examination revealed mucin deposition, fibroblast proliferation, and fibrosis, supporting the diagnosis. Serum protein electrophoresis identified IgG-λ type paraproteinemia. Notably, the patient had a history of hepatitis B virus (HBV) infection, suggesting a potential association. Following eight weeks of oral triamcinolone acetonide therapy, the skin lesions improved significantly. Despite established diagnostic criteria for SM, its pathogenesis remains poorly understood. Chronic antigenic stimulation from circulating cytokines and viral infections, such as HBV, may contribute to disease development. This case highlights the potential link between chronic HBV infection and SM, emphasizing the need for further investigation into viral etiologies. SM differs clinically, histologically, and systemically from related disorders such as scleroderma and scleroedema, necessitating careful differentiation for appropriate management. The scarcity of epidemiological data and lack of standardized treatment guidelines for SM in China underscore the challenges clinicians face in diagnosing and managing this rare disease. This case reinforces the importance of multidisciplinary collaboration, particularly when co-infections such as HBV are present. Given the chronic, unpredictable course of SM and its potential systemic involvement, continuous follow-up and vigilant monitoring are essential to optimize patient outcomes.

Keywords: hepatitis B virus; mucin; paraglobulin; scleromyxedema.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Clinical photographs illustrating the patient’s condition. (a) Initial presentation showing diffuse yellowish plaques on the nape of the neck, shoulders, back, and waist. The plaques had clear boundaries and formed a map-like appearance. The skin texture and hair appeared normal, with a slightly firm consistency that could be palpated without pain or sensory disturbances. (b) Significant improvement of the lesions observed after 8 weeks of treatment. (c) Absence of lesion recurrence during a follow-up visit 4 months after treatment.
Figure 2
Figure 2
Histopathological features of skin lesions. (a) The epidermis appears mostly normal, with liquefied degeneration of the basal lamina and extensive mucin deposition between the dermal collagen fibers (H&E, magnification ×50). (b) Focal fibrosis is observed in the dermis (H&E, magnification ×50). (c) Sparse infiltration of inflammatory cells, predominantly lymphocytes and a few fibroblasts is observed around the dermal blood vessels (H&E, magnification ×100). (d) Positive staining for Assyntolan is observed (H&E, magnification×200).

Similar articles

References

    1. Rongioletti F, Merlo G, Cinotti E, et al. Scleromyxedema: a multicenter study of characteristics, comorbidities, course, and therapy in 30 patients. J Am Acad Dermatol. 2013;69(1):66–72. doi:10.1016/j.jaad.2013.01.007 - DOI - PubMed
    1. Patel DR, Vora N, Chaudhary R, Sharma V, Dadhaniya NV. Scleredema adultorum of buschke associated with diffuse eosinophilia and Hepatitis B virus infection. Cureus. 2023;15(4):e38300. doi:10.7759/cureus.38300 - DOI - PMC - PubMed
    1. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D. The CARE guidelines: consensus-based clinical case reporting guideline development. Headache. 2013;53(10):1541–1547. doi:10.1111/head.12246 - DOI - PubMed
    1. Montgomery H, Underwood LJ. Lichen myxedematosus; differentiation from cutaneous myxedemas or mucoid states. J Invest Dermatol. 1953;20(3):213–236. doi:10.1038/jid.1953.25 - DOI - PubMed
    1. Rongioletti F, Rebora A. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol. 2001;44(2):273–281. doi:10.1067/mjd.2001.111630 - DOI - PubMed

Publication types

LinkOut - more resources